Just reading the budget announcements and considering the various companies I’m invested in. Of them GSS is in a prime position to benefit - R&D rebates preserved, no cap on instant asset write off - as they invest in machine and equipment to scale up - if they are profitable this year and it looks to be in the order of $20m profit the tax can be cash backed to fund expansion on FY 22 - if GSS didn’t have a suite of game changing products lined up - this wouldn’t be such a boost but it will really make every dollar generated able to be reinvested - as we try to break into Europe this is such a support for Aussie innovation. This super cycle is going to play out over the next few years. I can imagine pathology companies will be investing big time in machines. Thought tests - would sell everything they could make for the next few years... I didn’t think the machines would too. Very exciting times to be an investor backing innovation and start ups
- Forums
- ASX - By Stock
- Ann: First quarter sales update
Just reading the budget announcements and considering the...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GSS (ASX) to my watchlist
(20min delay)
|
|||||
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $181.2M |
Open | High | Low | Value | Volume |
79.0¢ | 80.0¢ | 77.0¢ | $307.5K | 390.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 296 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.780 |
1 | 12500 | 0.750 |
1 | 1000 | 0.740 |
3 | 16361 | 0.735 |
3 | 102069 | 0.730 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 296 | 1 |
0.820 | 8456 | 3 |
0.845 | 1184 | 1 |
0.850 | 23008 | 1 |
0.860 | 12935 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |